Literature DB >> 1260186

Proceedings: The nature of the bradykinin inactivating system in isolated lungs.

Y S Bakhle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1260186      PMCID： PMC1666912     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  8 in total

1.  Pulmonary angiotensin-converting enzyme. Structural and catalytic properties.

Authors:  M Das; R L Soffer
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

2.  Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.

Authors:  S L Engel; T R Schaeffer; B I Gold; B Rubin
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

Review 3.  Pharmacokinetic function of the pulmonary circulation.

Authors:  Y S Bakhle; J R Vane
Journal:  Physiol Rev       Date:  1974-10       Impact factor: 37.312

4.  Conversion of angiotensin I to angiotensin II in peripheral vascular beds of the rat.

Authors:  V A Kreye; F Gross
Journal:  Am J Physiol       Date:  1971-05

5.  Metabolism of the angiotensins in isolated perfused tissues.

Authors:  Y S Bakhle; A M Reynard; J R Vane
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

6.  Biologically active synthetic fragments of bradykinin.

Authors:  K Suzuki; T Abinko; N Endo; T Kameyama; K Sasaki
Journal:  Jpn J Pharmacol       Date:  1969-06

7.  Bradykinin analogs containing beta-homoamino acids.

Authors:  M A Ondetti; S L Engel
Journal:  J Med Chem       Date:  1975-07       Impact factor: 7.446

8.  The inactivation of bradykinin in the pulmonary circulation of isolated lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.